Last reviewed · How we verify
ZX-7101A dry suspension
ZX-7101A dry suspension is a Small molecule drug developed by Nanjing Zenshine Pharmaceuticals. It is currently in Phase 1 development.
At a glance
| Generic name | ZX-7101A dry suspension |
|---|---|
| Sponsor | Nanjing Zenshine Pharmaceuticals |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Assess the Safety and Efficacy of ZX-7101A for Oral Suspension in Chinese Pediatric Participants 2 to 11 Years of Age With Influenza (PHASE3)
- Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years With Influenza (PHASE3)
- Study to Evaluate the Pharmacokinetics and Relative Bioavailability of Metabolites in Healthy Chinese Adult Males (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ZX-7101A dry suspension CI brief — competitive landscape report
- ZX-7101A dry suspension updates RSS · CI watch RSS
- Nanjing Zenshine Pharmaceuticals portfolio CI
Frequently asked questions about ZX-7101A dry suspension
What is ZX-7101A dry suspension?
ZX-7101A dry suspension is a Small molecule drug developed by Nanjing Zenshine Pharmaceuticals.
Who makes ZX-7101A dry suspension?
ZX-7101A dry suspension is developed by Nanjing Zenshine Pharmaceuticals (see full Nanjing Zenshine Pharmaceuticals pipeline at /company/nanjing-zenshine-pharmaceuticals).
What development phase is ZX-7101A dry suspension in?
ZX-7101A dry suspension is in Phase 1.
Related
- Manufacturer: Nanjing Zenshine Pharmaceuticals — full pipeline
- Compare: ZX-7101A dry suspension vs similar drugs
- Pricing: ZX-7101A dry suspension cost, discount & access